Variant report
Variant | esv10363 |
---|---|
Chromosome Location | chr11:34015216-34018311 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:15)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:15 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:34012814..34016212-chr11:34072473..34075239,3 | MCF-7 | breast: | |
2 | chr11:34017302..34020894-chr11:34072155..34075321,5 | MCF-7 | breast: | |
3 | chr11:34018304..34019124-chr11:34380429..34381489,5 | MCF-7 | breast: | |
4 | chr11:34017787..34020470-chr11:34083587..34085765,2 | K562 | blood: | |
5 | chr11:34017694..34021670-chr11:34071468..34075941,12 | MCF-7 | breast: | |
6 | chr11:34018236..34019254-chr11:34072775..34073515,3 | MCF-7 | breast: | |
7 | chr11:34017030..34019308-chr11:34075054..34077905,2 | K562 | blood: | |
8 | chr11:34018287..34020760-chr11:34051667..34053419,2 | K562 | blood: | |
9 | chr11:34016768..34019238-chr11:34070653..34073628,2 | K562 | blood: | |
10 | chr11:33998966..34000482-chr11:34017921..34020175,2 | MCF-7 | breast: | |
11 | chr11:34013418..34015422-chr11:34129714..34132635,2 | K562 | blood: | |
12 | chr11:34017295..34020752-chr11:34087860..34091315,4 | K562 | blood: | |
13 | chr11:34016657..34020888-chr11:34127780..34130463,3 | K562 | blood: | |
14 | chr11:34018085..34021579-chr11:34051099..34053696,3 | K562 | blood: | |
15 | chr11:34017204..34020055-chr11:34021200..34023906,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000135372 | chromatin interactions |
ENSG00000135387 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142827830 | chr11:34015233-34015234 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs181159589 | chr11:34015237-34015238 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs34654540 | chr11:34015243-34015244 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs117276472 | chr11:34015254-34015255 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs373857871 | chr11:34015331-34015332 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs61880555 | chr11:34015362-34015363 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs184956196 | chr11:34015381-34015382 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs544652269 | chr11:34015397-34015398 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs546369193 | chr11:34015403-34015404 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs564486840 | chr11:34015420-34015421 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs375462034 | chr11:34015427-34015428 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs564571209 | chr11:34015479-34015480 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs576631058 | chr11:34015490-34015491 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs533335873 | chr11:34015493-34015494 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs547345710 | chr11:34015536-34015537 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs369468523 | chr11:34015556-34015557 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs529538610 | chr11:34015576-34015577 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs544139093 | chr11:34015577-34015578 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs549314983 | chr11:34015580-34015581 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs61880556 | chr11:34015581-34015582 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs569394526 | chr11:34015626-34015627 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs536764531 | chr11:34015665-34015666 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs150214305 | chr11:34015757-34015758 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs138843138 | chr11:34015782-34015783 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs539034011 | chr11:34015838-34015839 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs529329386 | chr11:34015871-34015872 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs566010283 | chr11:34015888-34015889 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs552886324 | chr11:34015889-34015890 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs35363861 | chr11:34015910-34015911 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs573049045 | chr11:34015911-34015912 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs542058203 | chr11:34016003-34016004 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs555280498 | chr11:34016005-34016006 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs7112270 | chr11:34016016-34016017 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs544738777 | chr11:34016060-34016061 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs564549704 | chr11:34016088-34016089 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs578095563 | chr11:34016149-34016150 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs540629086 | chr11:34016164-34016165 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs528158745 | chr11:34016166-34016167 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs560478897 | chr11:34016205-34016206 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs529570373 | chr11:34016237-34016238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73500839 | chr11:34016261-34016262 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs562964530 | chr11:34016264-34016265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559784979 | chr11:34016328-34016329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533308203 | chr11:34016329-34016330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189262750 | chr11:34016338-34016339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs146353786 | chr11:34016378-34016379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546189112 | chr11:34016392-34016393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs7112880 | chr11:34016393-34016394 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs535400467 | chr11:34016424-34016425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551503546 | chr11:34016481-34016482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 21364760 | CNVD |
Aniridia syndrome | 21572526 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Denys-drash syndrome | 21085971 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
WAGR syndrome | 16773131 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Aniridia syndrome | 17204608 | CNVD |
Mental retardation | 17204608 | CNVD |
WAGR syndrome | 19617690 | CNVD |
genitourinary abnormalities | 17204608 | CNVD |
Breast cancer | 16397240 | CNVD |
Mental retardation | 16773131 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17160897 | CNVD |
Cancer | 21183584 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
WAGR syndrome | 22470819 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Denys-drash syndrome | 19566914 | CNVD |
Familial wilms tumor | 19566914 | CNVD |
Frasier syndrome | 19566914 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
WAGR syndrome | 20603712 | CNVD |
Autism | 17322880 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21858162 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 16620391 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:34006400-34018200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr11:34013400-34018400 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
3 | chr11:34013400-34018800 | Weak transcription | Dnd41 | blood |
4 | chr11:34013600-34018400 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
5 | chr11:34016400-34018800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr11:34016400-34020400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
7 | chr11:34016600-34016800 | Enhancers | K562 | blood |
8 | chr11:34016800-34018400 | Weak transcription | K562 | blood |
9 | chr11:34017800-34018400 | Enhancers | Fetal Intestine Small | intestine |
10 | chr11:34017800-34019600 | Enhancers | Fetal Intestine Large | intestine |
11 | chr11:34018000-34018200 | Enhancers | Duodenum Mucosa | Duodenum |
12 | chr11:34018200-34018400 | Enhancers | Brain Angular Gyrus | brain |
13 | chr11:34018200-34018400 | Enhancers | Brain Substantia Nigra | brain |
14 | chr11:34018200-34018400 | Enhancers | Colonic Mucosa | Colon |
15 | chr11:34018200-34018400 | Active TSS | Hela-S3 | cervix |
16 | chr11:34018200-34018600 | Flanking Active TSS | Duodenum Mucosa | Duodenum |
17 | chr11:34018200-34018600 | Flanking Bivalent TSS/Enh | HepG2 | liver |
18 | chr11:34018200-34019200 | Enhancers | Brain Cingulate Gyrus | brain |
19 | chr11:34018200-34019400 | Bivalent Enhancer | Fetal Stomach | stomach |
20 | chr11:34018200-34019600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr11:34018200-34019600 | Enhancers | Brain Germinal Matrix | brain |